NCT00445796View on ClinicalTrials.gov

Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

June 30, 2005

Conditions

Malaria

Interventions

DRUG

Artesunate

DRUG

Amodiaquine

Trial Locations (2)

Unknown

Sanofi-Aventis, Yaoundé

Sanofi-Aventis, Dakar

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY